Compounds of Formula I:
wherein X, Y, Z, R
1
, R
2
, R
3
, R
4
are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other psychiatric, neurodegenerative and/or neurological disorders in mammals, including humans.